TPG Capital-backed Exactech acquired XpandOrtho.

TPG Capital-backed Exactech, a developer and producer of bone and joint restoration products and biologic solutions, acquired XpandOrtho, a designer of soft tissue balancing instruments for knee replacement surgery. Financial terms were not disclosed. According to Exactech CEO David Petty, “The acquisition of XpandOrtho supports Exactech’s growth strategy and commitment to improving surgeon experience and patient outcomes. Their innovative ligament balancing technology provides a strong framework for integration into our ExactechGPS system to further advance our award-winning Truliant® Total Knee System. We look forward to collaborating with XpandOrtho founders Cliff Colwell and Darryl D’Lima on continued development of advanced knee replacement technology.”